https://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-Announces-Phase-3-KEYNOTE-811-Trial-Met-Dual-Primary-Endpoint-of-Overall-Survival-as-First-Lin-46598469/?utm_source=telegram&utm_medium=social&utm_campaign=share